WO2023116718A1 - Method for preparing random sgrna library of target sequence by means of enzymatic method - Google Patents

Method for preparing random sgrna library of target sequence by means of enzymatic method Download PDF

Info

Publication number
WO2023116718A1
WO2023116718A1 PCT/CN2022/140437 CN2022140437W WO2023116718A1 WO 2023116718 A1 WO2023116718 A1 WO 2023116718A1 CN 2022140437 W CN2022140437 W CN 2022140437W WO 2023116718 A1 WO2023116718 A1 WO 2023116718A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
sgrna
random
target sequence
sequence
Prior art date
Application number
PCT/CN2022/140437
Other languages
French (fr)
Chinese (zh)
Inventor
宋东亮
刘倩
黄成�
侯策
王嫚
孙睿
陈晶晶
曹振
Original Assignee
翌圣生物科技(上海)股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 翌圣生物科技(上海)股份有限公司 filed Critical 翌圣生物科技(上海)股份有限公司
Publication of WO2023116718A1 publication Critical patent/WO2023116718A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms

Definitions

  • the application belongs to the field of biotechnology, and in particular relates to a method for preparing a random sgRNA library of target sequences by enzymatic method.
  • CRISPR gene editing technology Since its development, CRISPR gene editing technology has been widely used in various fields such as gene therapy, in vitro diagnosis, gene capture and target gene removal, and won the 2020 Nobel Prize in Physiology and Medicine. It is an efficient and practical technology.
  • the practical CRISPR system is mainly composed of two parts, one is the Cas protein with two endonuclease active sites, which is responsible for cutting the two strands of DNA at the target site; the other is the DNA pairing sequence with the target site
  • the guide RNA (sgRNA) that binds to the Cas protein sequence is responsible for recruiting the Cas protein and guiding the Cas protein to bind to the complementary paired target site.
  • the Cas protein first binds to the sgRNA to form a Cas-sgRNA complex, which is retrieved on the DNA.
  • the region complementary to the sgRNA protospacer, ProtoSpacer
  • the Cas protein unwinds the target site, making the unwound double-stranded DNA Entering the DNA cutting active domain of the Cas protein
  • the Cas protein cuts the double-stranded DNA, resulting in a double-strand DNA break.
  • the broken DNA is repaired by homologous recombination (HR) or non-homologous end joining (NHEJ) and other DNA damage repair methods to complete the editing of the target gene.
  • Cas proteins currently used for commercial applications mainly include Cas9, Cas12, Cas13, and Cas14 and their variants. Different Cas proteins recognize PAM sequences and requirements, and the length of ProtoSpacer is also different. Therefore, different CRISPR systems have different application scenarios.
  • sgRNA In addition to the purification and preparation of Cas protein, the in vitro construction and synthesis of sgRNA is also an important part of the commercial application of CRISPR.
  • Conventional methods need to use primer synthesis to synthesize target sgRNA primers containing the T7 promoter, then use overlapping PCR to obtain the full-length sgRNA backbone template, and use in vitro transcription to obtain the required sgRNA.
  • This method is time-consuming, low-cost, and highly controllable. It has been commercialized on a large scale and has become the main form of sgRNA preparation in vitro, but it still has the problem of low throughput.
  • Gene capture or removal usually requires the capture or removal of a large region of the genome, covering a length of 1Mbp or even the entire complete genomic DNA. This requires the design and synthesis of tens of millions of sgRNAs. In the design and synthesis of sgRNA, both cost and technology are great challenges.
  • the application provides a method for preparing an enzymatic target sequence random sgRNA library, the steps of which include:
  • Nt.CviPII cuts the PAM region of the target sequence to obtain fragmented double-stranded DNA, denatures the double-stranded DNA to obtain fragmented single-stranded DNA,
  • the denaturation treatment adopts conventional high temperature denaturation
  • step (1) In the reaction system of step (1), add the linker magnetic bead that contains BbsI restriction site, the 3 ' end of linker connects fragmented single-stranded DNA;
  • the sample DNA is genomic DNA, PCR product or DNA library.
  • the forward sequence of the adapter magnetic beads described in step (2) is /biotin/-TTTTTGAAGA (SEQ ID NO: 1)
  • the reverse sequence is /NH2C6/-NNNNNNNHGGTCTTCAAAAA-/NH2C6/ (SEQ ID NO: 2)
  • the two sequences are annealed at an equimolar concentration
  • the magnetic beads are streptavidin magnetic beads.
  • T4 DNA ligase or E.coli DNA ligase is used in step (2) to connect the fragmented DNA to the adapter.
  • the random primer described in step (4) is a random hexamer primer, and the extension adopts Klenow DNA polymerase.
  • the sgRNA backbone described in step (5) is a double-stranded DNA formed by complementary pairing of two single-stranded DNAs, wherein the forward sequence is /rApp/-CGGTTGGAGCTAGAAATAGCAAGTCAACCTAACGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-/NH2C6/ (SEQ ID NO: 3);
  • the directional sequence is /NH2C6/-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCGTTAGGTTGACTTGCTATTTCTAGCTCCAACC-/ddG/ (SEQ ID NO: 4).
  • T4 DNA ligase mutant K159L is used in step (5) to connect the sgRNA backbone with the double-stranded DNA.
  • step (7) uses T4 DNA ligase
  • the forward sequence of the T7 promoter is /NH2C6/-TTCTAATACGACTCACTATAGGNN (SEQ ID NO: 5)
  • the reverse sequence is /ddC/-CTATAGTGAGTCGTATTAGAA-/NH2C6/( SEQ ID NO:6).
  • the forward sequence of the primer pair used in the amplification reaction described in step (8) is TTCTAATACGACTCACTATAGG (SEQ ID NO: 7), and the reverse sequence is AAAAGCACCGACTCGGTGCC (SEQ ID NO: 8).
  • step (9) uses T7 RNA polymerase to perform transcription, and uses RNA recovery magnetic beads to recover the sgRNA library.
  • ERSP Enzymatical Random sgRNA Preparation
  • the principle and process of ERSP are as follows: Use the random nickase Nt.CviPII to cut the PAM region of the target sequence; DNA denaturation, magnetic beads are connected to the linker containing the BbsI recognition site; BbsI is cut to release the DNA; the sgRNA backbone containing MmeI is connected; Cut with MmeI to obtain the sequence of the protospacer region; connect to the T7 promoter; amplify to obtain the sgRNA library with the T7 promoter; transcribe in vitro to obtain the target sequence sgRNA library.
  • ERSP has the advantages of low cost, simple production, uniform coverage, small bias, no restriction on the length of the target sequence, and no need to design sgRNA in large quantities. It has important application value in the capture and removal of target genes.
  • Figure 1 is a schematic diagram of the principle and flow of ERSP technology.
  • Figure 2 shows the effect of different input amounts of Nt.CviPII on DNA fragmentation.
  • the left lane is 0.5U
  • the middle lane is 1U
  • the right lane is 2U.
  • Figure 3 is the DNA electrophoresis image after connecting the sgRNA backbone. On the left is 18S/28S DNA, and on the right is human whole genome DNA.
  • Figure 4 is the electrophoresis of the amplification products of the 18S/28S DNA (left) and the full coverage sgRNA library of human genome DNA (right) constructed by ERSP.
  • Figure 5 is the electrophoresis diagram of the sgRNA library prepared by in vitro transcription of the amplified products of the 18S/28S DNA (left) and the full-coverage sgRNA library of human genome DNA (right) constructed by ERSP.
  • Figure 6 shows the distribution of Nt.CviPII restriction sites on the DNA of 18S rRNA (shaded area).
  • Figure 7 shows the effect detection of 18S/28S ERSP library on CRISPR removal of rRNA.
  • Figure 8 is the detection of the effect of the human whole genome ERSP library on CRISPR removal of the human host genome.
  • BbsI-F and BbsI-R were dissolved in 100mM NaCl to 100 ⁇ M, mixed with equimolar concentration, reacted at 95°C for 5min, and decreased by 1°C per minute. After the reaction, the annealed linker was diluted to 10 ⁇ M with water. Take 20 ⁇ L of the diluted adapter, add 5 ⁇ L of streptavidin magnetic beads C1 (Thermo), and rotate and mix at room temperature for 30 min. Wash the magnetic beads 3 times with 100mM NaCl.
  • Skeleton annealing sg-F and sg-R were dissolved in 100mM NaCl solution to 100 ⁇ M, mixed with equimolar concentrations, reacted at 95°C for 5min, and decreased by 1°C per minute. After the reaction, the annealed matrix was diluted to 10 ⁇ M with water.
  • RNA beads After reacting at 37°C for 4h, add 10U DNase I (TAKARA), and react at 37°C for 1h. Add 50 ⁇ L Ampure RNA beads (Beckman) to recover RNA. The size of sgRNA was detected by agarose gel electrophoresis.
  • Example 2 Application of ERSP on removal of rRNA and host genome.
  • a random sgRNA library covering 18S rRNA and 28S rRNA was prepared using human RNA as a template; a random sgRNA library covering human genomic DNA was prepared using human genomic DNA as a template Library, referred to as ERSP library, and applied to rRNA removal and host genome removal.
  • ERSP library a template Library
  • Cas9-sgRNA library 5 ⁇ L RNA or DNA library 1-100ng 10 ⁇ NEB buffer 3.1 1 ⁇ L total capacity 10 ⁇ L
  • the prepared library was sequenced and analyzed on the Illumina NovaSeq 6000 platform after Qsep100 quality inspection.
  • Nt.CviPII restriction site has a wide random distribution on 18S rRNA (see Figure 6).
  • RNA library construction and sequencing are shown in Figure 7.
  • the sgRNA library prepared by ERSP method can effectively remove 18S and 28S rRNA.
  • the DNA library construction and sequencing results are shown in Figure 8.
  • the sgRNA library prepared by the ERSP method can effectively remove the human host genomic DNA during the DNA library construction process.
  • this application provides an enzymatic target sequence random sgRNA preparation method ERSP (Enzymatical Random sgRNA Preparation), which can prepare all sgRNA groups randomly covering the target region at one time.
  • ERSP Enzymatical Random sgRNA Preparation
  • the principle and process of ERSP are as follows: Use the random nickase Nt.CviPII to cut the PAM region of the target sequence; DNA denaturation, magnetic beads are connected to the linker containing the BbsI recognition site; BbsI is cut to release the DNA; the sgRNA backbone containing MmeI is connected; Cut with MmeI to obtain the sequence of the protospacer region; connect to the T7 promoter; amplify to obtain the sgRNA library with the T7 promoter; transcribe in vitro to obtain the target sequence sgRNA library.
  • ERSP has the advantages of low cost, simple production, uniform coverage, small bias, no restriction on the length of the target sequence, and no need to design

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided in the present invention is a method for preparing a random sgRNA library of a target sequence by means of an enzymatic method. The preparation method comprises the steps of: nicking a PAM region of the target sequence of sample DNA with a random nickase Nt.CviPII; linking the fragmented DNA to a linker magnetic bead containing a BbsI enzyme cleavage site; performing cleavage with BbsI to release DNA; performing random primer extension; linking same to an sgRNA skeleton containing an MmeI enzyme cleavage site; performing cleavage with MmeI to release a protospacer region; linking same to a T7 promoter sequence; performing amplification to obtain an sgRNA library template containing the T7 promoter; and finally obtaining the sgRNA library by means of in vitro transcription. According to the method for preparing a random sgRNA library of a target sequence by means of an enzymatic method in the present application, all sgRNA groups randomly covering a target region can be prepared at one time, and the method has the advantages of a low cost, simple production, uniform coverage, small bias, no limitation on the length of a target sequence, no need for large-design sgRNA, etc., and has an important application value in the capture and removal of target genes.

Description

酶法靶序列随机sgRNA文库的制备方法Enzymatic target sequence random sgRNA library preparation method 技术领域technical field
本申请属于生物技术领域,具体涉及一种酶法靶序列随机sgRNA文库的制备方法。The application belongs to the field of biotechnology, and in particular relates to a method for preparing a random sgRNA library of target sequences by enzymatic method.
背景技术Background technique
CRISPR基因编辑技术自从被开发出来就被广泛应用在基因治疗、体外诊断、基因捕获和靶基因去除等各个领域,并获得2020年诺贝尔生理医学奖,是一种高效且实用的技术。实用型CRISPR系统主要有两个部分组成,一个是具有两个核酸内切酶活性位点的Cas蛋白,负责切割靶位点DNA的两条链;另一个是具有与靶位点处DNA配对序列和Cas蛋白结合序列的引导RNA(sgRNA),负责募集Cas蛋白并引导Cas蛋白结合到互补配对的靶位点上。在CRISPR系统中,Cas蛋白先与sgRNA结合形成Cas-sgRNA复合物,并在DNA上进行检索。当检索到与sgRNA互补配对的区域(原间隔区域,ProtoSpacer),并且ProtoSpacer区域的3’端存在NGG序列(PAM序列)时,Cas蛋白将靶位点进行解旋,使得解开的双链DNA进入到Cas蛋白的DNA切割活性结构域,Cas蛋白对双链DNA进行切割,产生双链DNA断裂。断裂的DNA通过同源重组修复HR或者非同源末端连接NHEJ等DNA损伤修复方式完成靶基因的编辑。目前用于商业化应用的Cas蛋白主要有Cas9、Cas12、Cas13和Cas14及其变体,不同的Cas蛋白识别的PAM序列和要求,ProtoSpacer的长度也不同。因此,不同的CRISPR系统的具有不同的应用场景。Since its development, CRISPR gene editing technology has been widely used in various fields such as gene therapy, in vitro diagnosis, gene capture and target gene removal, and won the 2020 Nobel Prize in Physiology and Medicine. It is an efficient and practical technology. The practical CRISPR system is mainly composed of two parts, one is the Cas protein with two endonuclease active sites, which is responsible for cutting the two strands of DNA at the target site; the other is the DNA pairing sequence with the target site The guide RNA (sgRNA) that binds to the Cas protein sequence is responsible for recruiting the Cas protein and guiding the Cas protein to bind to the complementary paired target site. In the CRISPR system, the Cas protein first binds to the sgRNA to form a Cas-sgRNA complex, which is retrieved on the DNA. When the region complementary to the sgRNA (protospacer, ProtoSpacer) is retrieved, and there is an NGG sequence (PAM sequence) at the 3' end of the ProtoSpacer region, the Cas protein unwinds the target site, making the unwound double-stranded DNA Entering the DNA cutting active domain of the Cas protein, the Cas protein cuts the double-stranded DNA, resulting in a double-strand DNA break. The broken DNA is repaired by homologous recombination (HR) or non-homologous end joining (NHEJ) and other DNA damage repair methods to complete the editing of the target gene. Cas proteins currently used for commercial applications mainly include Cas9, Cas12, Cas13, and Cas14 and their variants. Different Cas proteins recognize PAM sequences and requirements, and the length of ProtoSpacer is also different. Therefore, different CRISPR systems have different application scenarios.
除Cas蛋白的纯化和制备外,sgRNA的体外构建和合成也是CRISPR商业化应用的重要环节。常规的方法需要利用引物合成的方式合成含T7启动子的靶标sgRNA引物,再利用重叠PCR获得全长sgRNA骨架模板,并利用体外转录的方法获得需要的sgRNA。这种方法耗时短、成本低、可控性高,已经大规模商业化,成为sgRNA体外制备的主要形式,但仍存在通量低的问题。基因捕获或者去除通常需要对大区域的基因组进行捕获或者去除,需要覆盖长度达1Mbp甚至整个完整的基因组DNA。这需要设计和合成千万级别条数的sgRNA。在sgRNA的设计合成上,无论成本还是技术都是很大的挑战。In addition to the purification and preparation of Cas protein, the in vitro construction and synthesis of sgRNA is also an important part of the commercial application of CRISPR. Conventional methods need to use primer synthesis to synthesize target sgRNA primers containing the T7 promoter, then use overlapping PCR to obtain the full-length sgRNA backbone template, and use in vitro transcription to obtain the required sgRNA. This method is time-consuming, low-cost, and highly controllable. It has been commercialized on a large scale and has become the main form of sgRNA preparation in vitro, but it still has the problem of low throughput. Gene capture or removal usually requires the capture or removal of a large region of the genome, covering a length of 1Mbp or even the entire complete genomic DNA. This requires the design and synthesis of tens of millions of sgRNAs. In the design and synthesis of sgRNA, both cost and technology are great challenges.
发明内容Contents of the invention
本申请提供了一种酶法靶序列随机sgRNA文库的制备方法,其步骤包括:The application provides a method for preparing an enzymatic target sequence random sgRNA library, the steps of which include:
(1)采用随机切口酶Nt.CviPII处理样本DNA,Nt.CviPII对目标序列的PAM区域进行切口,获得片段化的双链DNA,对双链DNA进行变性处理,获得片段化的单链DNA,其中,所述变性处理采用常规的高温变性;(1) Treat sample DNA with random nickase Nt.CviPII, Nt.CviPII cuts the PAM region of the target sequence to obtain fragmented double-stranded DNA, denatures the double-stranded DNA to obtain fragmented single-stranded DNA, Wherein, the denaturation treatment adopts conventional high temperature denaturation;
(2)在步骤(1)的反应体系中加入含BbsI酶切位点的接头磁珠,接头的3’端连接片段化的单链DNA;(2) In the reaction system of step (1), add the linker magnetic bead that contains BbsI restriction site, the 3 ' end of linker connects fragmented single-stranded DNA;
(3)将磁珠连接的DNA采用BbsI酶切割,释放出单链DNA;(3) Cut the DNA connected to the magnetic beads with BbsI enzyme to release the single-stranded DNA;
(4)随机引物延伸,使单链DNA形成双链DNA;(4) Random primer extension to make single-stranded DNA form double-stranded DNA;
(5)在双链DNA的3’端上连接含有MmeI酶切位点的sgRNA骨架;(5) connecting the sgRNA backbone containing the MmeI restriction site on the 3' end of the double-stranded DNA;
(6)采用MmeI切割步骤(5)的连接产物,释放原间隔区域;(6) Cutting the ligation product of step (5) with MmeI to release the protospacer region;
(7)在原间隔区域上的5’端连接T7启动子序列;(7) connecting the T7 promoter sequence at the 5' end of the original spacer region;
(8)扩增获得含T7启动子的sgRNA文库模板;和(8) amplification obtains the sgRNA library template containing T7 promoter; and
(9)体外转录获得sgRNA文库。(9) In vitro transcription to obtain sgRNA library.
优选地,所述样本DNA为基因组DNA、PCR产物或者DNA文库。Preferably, the sample DNA is genomic DNA, PCR product or DNA library.
优选地,步骤(2)中所述接头磁珠的接头正向序列为/biotin/-TTTTTGAAGA(SEQ ID NO:1),反向序列为/NH2C6/-NNNNNNNHGGTCTTCAAAAA-/NH2C6/(SEQ ID NO:2),两个序列在等摩尔浓度下进行退火,所述磁珠为链亲和霉素磁珠。Preferably, the forward sequence of the adapter magnetic beads described in step (2) is /biotin/-TTTTTGAAGA (SEQ ID NO: 1), and the reverse sequence is /NH2C6/-NNNNNNNHGGTCTTCAAAAA-/NH2C6/ (SEQ ID NO: 2), the two sequences are annealed at an equimolar concentration, and the magnetic beads are streptavidin magnetic beads.
优选地,步骤(2)中采用T4 DNA连接酶或者E.coli DNA连接酶将片段化的DNA连接到接头上。Preferably, T4 DNA ligase or E.coli DNA ligase is used in step (2) to connect the fragmented DNA to the adapter.
优选地,步骤(4)中所述的随机引物为随机六聚体引物,延伸采用Klenow DNA聚合酶。Preferably, the random primer described in step (4) is a random hexamer primer, and the extension adopts Klenow DNA polymerase.
优选地,步骤(5)中所述的sgRNA骨架为两条单链DNA互补配对形成的双链DNA,其中正向序列为/rApp/-CGGTTGGAGCTAGAAATAGCAAGTCAACCTAACGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-/NH2C6/(SEQ ID NO:3);反向序列为/NH2C6/-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCGTTAGGTTGACTTGCTATTTCTAGCTCCAACC-/ddG/(SEQ ID NO:4)。Preferably, the sgRNA backbone described in step (5) is a double-stranded DNA formed by complementary pairing of two single-stranded DNAs, wherein the forward sequence is /rApp/-CGGTTGGAGCTAGAAATAGCAAGTCAACCTAACGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-/NH2C6/ (SEQ ID NO: 3); The directional sequence is /NH2C6/-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCGTTAGGTTGACTTGCTATTTCTAGCTCCAACC-/ddG/ (SEQ ID NO: 4).
优选地,步骤(5)中使用T4 DNA连接酶突变体K159L连接sgRNA骨架与双链DNA。Preferably, T4 DNA ligase mutant K159L is used in step (5) to connect the sgRNA backbone with the double-stranded DNA.
优选地,步骤(7)采用T4 DNA连接酶,所述的T7启动子正向序列为/NH2C6/-TTCTAATACGACTCACTATAGGNN(SEQ ID NO:5),反向序列为/ddC/-CTATAGTGAGTCGTATTAGAA-/NH2C6/(SEQ ID NO:6)。Preferably, step (7) uses T4 DNA ligase, the forward sequence of the T7 promoter is /NH2C6/-TTCTAATACGACTCACTATAGGNN (SEQ ID NO: 5), and the reverse sequence is /ddC/-CTATAGTGAGTCGTATTAGAA-/NH2C6/( SEQ ID NO:6).
优选地,步骤(8)中所述的扩增反应采用的引物对的正向序列为TTCTAATACGACTCACTATAGG(SEQ ID NO:7),反向序列为AAAAGCACCGACTCGGTGCC(SEQ ID NO:8)。Preferably, the forward sequence of the primer pair used in the amplification reaction described in step (8) is TTCTAATACGACTCACTATAGG (SEQ ID NO: 7), and the reverse sequence is AAAAGCACCGACTCGGTGCC (SEQ ID NO: 8).
优选地,步骤(9)采用T7 RNA聚合酶进行转录,采用RNA回收磁珠回收sgRNA文库。Preferably, step (9) uses T7 RNA polymerase to perform transcription, and uses RNA recovery magnetic beads to recover the sgRNA library.
本申请具有如下的有益效果:The application has the following beneficial effects:
本申请的酶法靶序列随机sgRNA文库的制备方法ERSP(Enzymatical Random sgRNA Preparation),可以一次性制备随机覆盖目标区域的所有sgRNA组。ERSP的原理和流程如下:使用随机切口酶Nt.CviPII对目标序列的PAM区域进行切口;DNA变性,磁珠连接含BbsI识别位点的接头;BbsI切割,释放DNA;连接含MmeI的sgRNA骨架;MmeI切割,获得原间隔区域序列;连接T7启动子;扩增获得带T7启动子的sgRNA文库;体外转录获得靶序列sgRNA文库。ERSP具有成本低、制作简单、覆盖均一、偏好性小、不受靶序列长度限制和无需大批量设计sgRNA等优点,在靶基因的捕获和去除上具有重要的应用价值。The enzymatic target sequence random sgRNA preparation method ERSP (Enzymatical Random sgRNA Preparation) of this application can prepare all sgRNA groups randomly covering the target region at one time. The principle and process of ERSP are as follows: Use the random nickase Nt.CviPII to cut the PAM region of the target sequence; DNA denaturation, magnetic beads are connected to the linker containing the BbsI recognition site; BbsI is cut to release the DNA; the sgRNA backbone containing MmeI is connected; Cut with MmeI to obtain the sequence of the protospacer region; connect to the T7 promoter; amplify to obtain the sgRNA library with the T7 promoter; transcribe in vitro to obtain the target sequence sgRNA library. ERSP has the advantages of low cost, simple production, uniform coverage, small bias, no restriction on the length of the target sequence, and no need to design sgRNA in large quantities. It has important application value in the capture and removal of target genes.
附图说明Description of drawings
图1为ERSP技术的原理和流程示意图。Figure 1 is a schematic diagram of the principle and flow of ERSP technology.
图2为不同Nt.CviPII投入量对DNA片段化的影响。左边泳道是0.5U,中间泳道是1U,右边泳道是2U。Figure 2 shows the effect of different input amounts of Nt.CviPII on DNA fragmentation. The left lane is 0.5U, the middle lane is 1U, and the right lane is 2U.
图3为连接sgRNA骨架后的DNA电泳图。左边是18S/28S DNA,右边是人全基因组DNA。Figure 3 is the DNA electrophoresis image after connecting the sgRNA backbone. On the left is 18S/28S DNA, and on the right is human whole genome DNA.
图4为ERSP构建18S/28S DNA(左)和人全基因组DNA(右)的全覆盖sgRNA库的扩增产物电泳图。Figure 4 is the electrophoresis of the amplification products of the 18S/28S DNA (left) and the full coverage sgRNA library of human genome DNA (right) constructed by ERSP.
图5为ERSP构建18S/28S DNA(左)和人全基因组DNA(右)的全覆盖 sgRNA库的扩增产物体外转录制备sgRNA库电泳图。Figure 5 is the electrophoresis diagram of the sgRNA library prepared by in vitro transcription of the amplified products of the 18S/28S DNA (left) and the full-coverage sgRNA library of human genome DNA (right) constructed by ERSP.
图6为18S rRNA的DNA上Nt.CviPII酶切位点分布情况(阴影区域)。Figure 6 shows the distribution of Nt.CviPII restriction sites on the DNA of 18S rRNA (shaded area).
图7为18S/28S ERSP库在CRISPR去除rRNA上是效果检测。Figure 7 shows the effect detection of 18S/28S ERSP library on CRISPR removal of rRNA.
图8为人全基因组ERSP库在CRISPR去除人类宿主基因组上的效果检测。Figure 8 is the detection of the effect of the human whole genome ERSP library on CRISPR removal of the human host genome.
具体实施方式Detailed ways
为了进一步描述使本申请的具体内容,以下结合实施例对本申请进行详细说明。实施例所涉及的操作方法及试剂为业内技术人员所熟知,应当理解,以下所描述的具体实施例仅仅用于对申请进行详细说明,但本申请的实施方式并不受下述实施例的限制。本实施例所使用的接头序列及修饰如表1所示,N为A、T、C、G中的任意碱基。ERSP的流程如图1所示。In order to further describe the specific content of the present application, the present application will be described in detail below in conjunction with the embodiments. The operating methods and reagents involved in the examples are well known to those skilled in the art. It should be understood that the specific examples described below are only used to describe the application in detail, but the implementation of the application is not limited by the following examples . The adapter sequences and modifications used in this example are shown in Table 1, and N is any base among A, T, C, and G. The process of ERSP is shown in Figure 1.
表1 接头序列及修饰Table 1 Linker sequences and modifications
Figure PCTCN2022140437-appb-000001
Figure PCTCN2022140437-appb-000001
Figure PCTCN2022140437-appb-000002
Figure PCTCN2022140437-appb-000002
实施例1:ERSP的流程Example 1: ERSP process
(1)制备含Bbs接头的磁珠(1) Preparation of magnetic beads containing Bbs linker
BbsI-F和BbsI-R用100mM NaCl溶解成100μM,等摩尔浓度混合后,95℃反应5min,每分钟降低1℃。反应结束后,用水将退火好的接头稀释至10μM。取20μL稀释好的接头,加入5μL链霉亲和素磁珠C1(Thermo),室温旋转混合30min。100mM NaCl清洗磁珠3次。BbsI-F and BbsI-R were dissolved in 100mM NaCl to 100μM, mixed with equimolar concentration, reacted at 95°C for 5min, and decreased by 1°C per minute. After the reaction, the annealed linker was diluted to 10 μM with water. Take 20 μL of the diluted adapter, add 5 μL of streptavidin magnetic beads C1 (Thermo), and rotate and mix at room temperature for 30 min. Wash the magnetic beads 3 times with 100mM NaCl.
(2)识别PAM序列的限制酶切割(2) Restriction enzyme cleavage that recognizes the PAM sequence
表2 限制酶酶切体系Table 2 Restriction enzyme digestion system
组分components 用量Dosage
人基因组DNAhuman genomic DNA 1μg1μg
10×rCutSmart buffer10×rCutSmart buffer 1μL1μL
Nt.CviPII(NEB)Nt.CviPII (NEB) 0.5-2U0.5-2U
补水至Hydrate to 10μL10μL
37℃反应30min,98℃反应10min,立即置于冰上。不同Nt.CviPII投入量对DNA片段化的影响如图2所示。React at 37°C for 30 minutes, react at 98°C for 10 minutes, and place on ice immediately. The effect of different input amounts of Nt.CviPII on DNA fragmentation is shown in Figure 2.
表3 含BbsI酶切位点的接头磁珠连接Table 3 Linker magnetic beads with BbsI restriction site
组分components 用量Dosage
上述反应体系The above reaction system 10μL10 μL
50%PEG800050%PEG8000 8μL8μL
10×T4 Ligase Reaction Buffer10×T4 Ligase Reaction Buffer 5μL5μL
补水至Hydrate to 50μL50μL
将配制含的反应体系重悬磁珠,加入2000U T4 DNA Ligase(NEB)混匀后,20℃连接1h,每3min震荡15s,转速为1000rpm/min。反应结束后,100mM NaCl清洗磁珠3次。按照说明书配制BbsI(NEB)反应体系30μL(10U),重悬磁珠,37℃消化1h,每3min震荡15s,转速为1000rpm/min。反应结束后,取上清。94℃反应10min,立即置于冰上。Resuspend the magnetic beads in the prepared reaction system, add 2000U T4 DNA Ligase (NEB) and mix well, connect at 20°C for 1h, shake for 15s every 3min, and rotate at 1000rpm/min. After the reaction, the magnetic beads were washed 3 times with 100mM NaCl. Prepare 30 μL (10 U) of BbsI (NEB) reaction system according to the instructions, resuspend the magnetic beads, digest at 37°C for 1 hour, shake for 15 seconds every 3 minutes, and rotate at 1000 rpm/min. After the reaction, take the supernatant. React at 94°C for 10 min, and place on ice immediately.
表4 随机引物延伸体系Table 4 Random primer extension system
组分components 用量Dosage
上述反应体系The above reaction system 30μL30μL
1mM N61mM N6 1μL1μL
10×NEBuffer TM 2 10 x NEBuffer 2 3μL3μL
Klenow fragment(NEB)Klenow fragment(NEB) 10U10U
补水至Hydrate to 60μL60μL
37℃反应20min。60℃反应5min。React at 37°C for 20 minutes. React at 60°C for 5 minutes.
(3)含旁切活性限制酶酶切位点的sgRNA骨架连接(3) sgRNA backbone connection with side-cutting active restriction enzyme cleavage site
骨架退火:sg-F和sg-R用100mM NaCl溶液溶解至100μM,等摩尔浓度混合后,95℃反应5min,每分钟降低1℃。反应结束后,用水将退火好的骨架稀释至10μM。Skeleton annealing: sg-F and sg-R were dissolved in 100mM NaCl solution to 100μM, mixed with equimolar concentrations, reacted at 95°C for 5min, and decreased by 1°C per minute. After the reaction, the annealed matrix was diluted to 10 μM with water.
表5 骨架连接体系Table 5 Skeleton connection system
组分components 用量Dosage
上述反应体系The above reaction system 60μL60μL
10μM sgRNA骨架接头10 μM sgRNA Backbone Adapter 5μL5μL
10×T4 Ligase Reaction Buffer10×T4 Ligase Reaction Buffer 5μL5μL
50%PEG800050%PEG8000 10μL10 μL
T4 DNA Ligase(K159L)T4 DNA Ligase(K159L) 2000U2000U
补水至Hydrate to 100μL100μL
20℃反应30min。反应结束后,加入50μL Ampure DNA beads回收DNA。22μL水洗脱。DNA凝胶回收140bp以上的序列。连接sgRNA骨架后的DNA 电泳图如图3所示。React at 20°C for 30 minutes. After the reaction, add 50 μL Ampure DNA beads to recover DNA. 22 μL water for elution. Sequences above 140bp were recovered from DNA gel. The DNA electrophoresis image after connecting the sgRNA backbone is shown in Figure 3.
(5)MmeI酶切(5) MmeI digestion
表6Table 6
组分components 用量Dosage
上述回收的DNADNA recovered from above 20μL20 μL
10×rCutSmart buffer10×rCutSmart buffer 3μL3μL
MmeIMmeI 5U5U
补水至Hydrate to 30μL30μL
37℃反应2h。反应结束后,加入70μL Ampure DNA beads回收DNA。42μL水洗脱。Reaction at 37°C for 2h. After the reaction, add 70 μL Ampure DNA beads to recover DNA. 42 μL water for elution.
(6)T7启动子连接(6) T7 promoter connection
接头退火:T7-F和T7-R用100mM NaCl溶液溶解至100μM,取10μL T7-F和10μL T7-R于PCR管中。95℃反应5min,每分钟降低1℃。反应结束后,用水将退火好的接头稀释至10μM。Joint annealing: Dissolve T7-F and T7-R with 100mM NaCl solution to 100μM, take 10μL T7-F and 10μL T7-R in a PCR tube. React at 95°C for 5 minutes, decreasing by 1°C per minute. After the reaction, the annealed linker was diluted to 10 μM with water.
表7 接头连接体系:Table 7 Joint connection system:
组分components 用量Dosage
上述回收的DNADNA recovered from above 40μL40μL
10μM T7接头10 μM T7 linker 5μL5μL
10×T4 Ligase Reaction Buffer10×T4 Ligase Reaction Buffer 5μL5μL
T4 DNA LigaseT4 DNA Ligase 2000U2000U
补水至Hydrate to 50μL50μL
20℃反应1h。反应结束后,加入22.5μL Ampure DNA beads回收DNA,去除掉未连接的接头。22μL水洗脱。Reaction at 20°C for 1h. After the reaction, add 22.5 μL Ampure DNA beads to recover the DNA and remove the unconnected adapters. 22 μL water for elution.
(5)sgRNA库扩增(5) sgRNA library amplification
表8 sgRNA库扩增体系Table 8 sgRNA library amplification system
组分components 用量Dosage
上述回收的DNADNA recovered from above 20μL20 μL
10μM sgPCR-F/R10 μM sgPCR-F/R 5μL5μL
Phusion High-Fidelity PCR Master MixPhusion High-Fidelity PCR Master Mix 25μL25 μL
补水至Hydrate to 50μL50μL
在98℃变性3min后,通过98℃ 10s变性、60℃ 20s退火和72℃ 10s延伸进行文库循环扩增。扩增产物使用70μL Ampure DNA beads进行回收,22μL DEPC水洗脱。扩增产物电泳图如图4所示。After denaturation at 98°C for 3 min, library cycles were amplified by denaturation at 98°C for 10 s, annealing at 60°C for 20 s, and extension at 72°C for 10 s. The amplified product was recovered with 70 μL Ampure DNA beads and eluted with 22 μL DEPC water. The electropherogram of the amplification product is shown in Figure 4.
(6)sgRNA库体外转录(6) In vitro transcription of sgRNA library
表9Table 9
组分components 用量Dosage
上述回收的DNADNA recovered from above 1μg1μg
10×Transcription Buffer10×Transcription Buffer 2μL2μL
CTP/GTP/ATP/UTP(100mM each)CTP/GTP/ATP/UTP(100mM each) 2μL2μL
T7 RNA Polymerase Mix(Yeasen)T7 RNA Polymerase Mix(Yeasen) 2μL2μL
补水至Hydrate to 20μL20 μL
37℃反应4h后,加入10U DNase I(TAKARA),37℃反应1h。加入50μL Ampure RNA beads(Beckman)回收RNA。琼脂糖凝胶电泳检测sgRNA大小。After reacting at 37°C for 4h, add 10U DNase I (TAKARA), and react at 37°C for 1h. Add 50 μL Ampure RNA beads (Beckman) to recover RNA. The size of sgRNA was detected by agarose gel electrophoresis.
扩增产物体外转录制备sgRNA库电泳图如图5所示。The electropherogram of the sgRNA library prepared by in vitro transcription of the amplified product is shown in Figure 5.
实施例2:ERSP在rRNA和宿主基因组去除上的应用。Example 2: Application of ERSP on removal of rRNA and host genome.
在本实施例中,先按照实施例1中的ERSP方法,以人RNA为模板制备了覆盖18S rRNA和28S rRNA的随机sgRNA库;以人基因组DNA为模板,制备了覆盖人类基因组DNA的随机sgRNA库,简称ERSP库,并应用在rRNA去除和宿主基因组去除上。具体实施方式如下:In this example, according to the ERSP method in Example 1, a random sgRNA library covering 18S rRNA and 28S rRNA was prepared using human RNA as a template; a random sgRNA library covering human genomic DNA was prepared using human genomic DNA as a template Library, referred to as ERSP library, and applied to rRNA removal and host genome removal. The specific implementation is as follows:
表10 sgRNA库与Cas9蛋白预组装:Table 10 sgRNA library and Cas9 protein pre-assembly:
组分components 用量Dosage
ERSP库ERSP library 2-10μg2-10μg
Cas9(NEB)Cas9 (NEB) 0.2-0.5μg0.2-0.5μg
500mM氯化钠500mM NaCl 1μL1μL
总体积total capacity 5μL5μL
37℃ 30min。37°C for 30min.
表11 CRISPR切割Table 11 CRISPR cleavage
组分components 用量Dosage
Cas9-sgRNA库Cas9-sgRNA library 5μL5μL
RNA或DNA文库RNA or DNA library 1-100ng1-100ng
10×NEB buffer 3.110×NEB buffer 3.1 1μL1μL
总体积total capacity 10μL10 μL
37℃ 30-90min,90℃ 10min。37°C for 30-90min, 90°C for 10min.
(5)文库扩增(5) Library amplification
表12Table 12
组分components 用量Dosage
上述反应体系The above reaction system 10μL10μL
Index Primer F/R(Yeasen,12610)Index Primer F/R(Yeasen,12610) 5μL5μL
2×Canace PCR mix2×Canace PCR mix 25μL25 μL
补水至Hydrate to 50μL50μL
在98℃变性3min后,通过98℃ 10s变性、60℃ 30s退火和72℃ 30s延伸进行文库循环扩增。扩增产物使用45μL Ampure DNA beads进行回收,22μL DEPC水洗脱。After denaturation at 98°C for 3 min, library cycles were amplified by denaturation at 98°C for 10 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s. The amplified product was recovered with 45 μL Ampure DNA beads and eluted with 22 μL DEPC water.
制备好的文库经过Qsep100质检后,在Illumina的NovaSeq 6000平台上进行测序并分析。The prepared library was sequenced and analyzed on the Illumina NovaSeq 6000 platform after Qsep100 quality inspection.
Nt.CviPII酶切位点在18S rRNA上具有广泛的随机分布(见图6)。Nt.CviPII restriction site has a wide random distribution on 18S rRNA (see Figure 6).
RNA建库测序结果如图7所示,ERSP方法制备的sgRNA文库能够有效去除18S和28S rRNA。DNA建库测序结果如图8所示,ERSP方法制备的sgRNA文库能够有效去除DNA建库过程中的人类宿主基因组DNA。The results of RNA library construction and sequencing are shown in Figure 7. The sgRNA library prepared by ERSP method can effectively remove 18S and 28S rRNA. The DNA library construction and sequencing results are shown in Figure 8. The sgRNA library prepared by the ERSP method can effectively remove the human host genomic DNA during the DNA library construction process.
综上,本申请提供了一种酶法靶序列随机sgRNA的制备方法ERSP(Enzymatical Random sgRNA Preparation),可以一次性制备随机覆盖目标区域的所有sgRNA组。ERSP的原理和流程如下:使用随机切口酶Nt.CviPII对目标序列的PAM区域进行切口;DNA变性,磁珠连接含BbsI识别位点的接头;BbsI切割,释放DNA;连接含MmeI的sgRNA骨架;MmeI切割,获得原间隔区域序列;连接T7启动子;扩增获得带T7启动子的sgRNA文库;体外转录获得靶序列sgRNA文库。ERSP具有成本低、制作简单、覆盖均一、偏好性小、不受靶序列长度限制和无需大批量设计sgRNA等优点,在靶基因的捕获和去除上具 有重要的应用价值。In summary, this application provides an enzymatic target sequence random sgRNA preparation method ERSP (Enzymatical Random sgRNA Preparation), which can prepare all sgRNA groups randomly covering the target region at one time. The principle and process of ERSP are as follows: Use the random nickase Nt.CviPII to cut the PAM region of the target sequence; DNA denaturation, magnetic beads are connected to the linker containing the BbsI recognition site; BbsI is cut to release the DNA; the sgRNA backbone containing MmeI is connected; Cut with MmeI to obtain the sequence of the protospacer region; connect to the T7 promoter; amplify to obtain the sgRNA library with the T7 promoter; transcribe in vitro to obtain the target sequence sgRNA library. ERSP has the advantages of low cost, simple production, uniform coverage, small bias, no restriction on the length of the target sequence, and no need to design sgRNA in large quantities. It has important application value in the capture and removal of target genes.

Claims (10)

  1. 一种酶法靶序列随机sgRNA文库的制备方法,其步骤包括:A method for preparing an enzymatic target sequence random sgRNA library, the steps comprising:
    (1)采用随机切口酶Nt.CviPII处理样本DNA,Nt.CviPII对目标序列的PAM区域进行切口获得片段化的双链DNA,对双链DNA进行变性处理,获得片段化的单链DNA;(1) Treat sample DNA with random nickase Nt.CviPII, Nt.CviPII cuts the PAM region of the target sequence to obtain fragmented double-stranded DNA, denatures the double-stranded DNA to obtain fragmented single-stranded DNA;
    (2)在步骤(1)的反应体系中加入含BbsI酶切位点的接头磁珠,接头的3’端连接片段化的单链DNA;(2) In the reaction system of step (1), add the linker magnetic bead that contains BbsI restriction site, the 3 ' end of linker connects fragmented single-stranded DNA;
    (3)将磁珠连接的DNA采用BbsI酶切割,释放出单链DNA;(3) Cut the DNA connected to the magnetic beads with BbsI enzyme to release the single-stranded DNA;
    (4)随机引物延伸,使单链DNA形成双链DNA;(4) Random primer extension to make single-stranded DNA form double-stranded DNA;
    (5)在双链DNA的3’端连接含有MmeI酶切位点的sgRNA骨架;(5) connecting the sgRNA backbone containing the MmeI restriction site at the 3' end of the double-stranded DNA;
    (6)采用MmeI切割步骤(5)的连接产物,释放原间隔区域;(6) Cutting the ligation product of step (5) with MmeI to release the protospacer region;
    (7)在原间隔区域的5’端连接T7启动子序列;(7) connecting the T7 promoter sequence at the 5' end of the original spacer region;
    (8)扩增获得含T7启动子的sgRNA文库模板;和(8) amplification obtains the sgRNA library template containing T7 promoter; and
    (9)体外转录获得sgRNA文库。(9) In vitro transcription to obtain sgRNA library.
  2. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,所述样本DNA为基因组DNA、PCR产物或者DNA文库。The method for preparing a random sgRNA library with enzymatic target sequences according to claim 1, wherein the sample DNA is genomic DNA, a PCR product or a DNA library.
  3. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(2)中所述接头磁珠的接头正向序列为/biotin/-TTTTTGAAGA(SEQ ID NO:1),反向序列为/NH2C6/-NNNNNNNHGGTCTTCAAAAA-/NH2C6/(SEQ ID NO:2),两个序列在等摩尔浓度下进行退火,所述磁珠为链亲和霉素磁珠。The preparation method of the enzymatic target sequence random sgRNA library according to claim 1, wherein, the linker forward sequence of the adapter magnetic beads described in step (2) is /biotin/-TTTTTGAAGA (SEQ ID NO: 1), and the reverse The sequence is /NH2C6/-NNNNNNNHGGTCTTCAAAAA-/NH2C6/ (SEQ ID NO: 2), the two sequences are annealed at an equimolar concentration, and the magnetic beads are streptavidin magnetic beads.
  4. 根据权利要求3所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(2)中采用T4 DNA连接酶或者E.coli DNA连接酶将片段化的DNA连接到接头上。The method for preparing a random sgRNA library of enzymatic target sequences according to claim 3, wherein in step (2), T4 DNA ligase or E.coli DNA ligase is used to connect the fragmented DNA to the adapter.
  5. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(4)中所述的随机引物为6碱基随机引物,延伸采用Klenow DNA聚合酶。The preparation method of the enzymatic target sequence random sgRNA library according to claim 1, wherein the random primer described in step (4) is a 6-base random primer, and the extension adopts Klenow DNA polymerase.
  6. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(5)中所述的sgRNA骨架为两条单链DNA互补配对形成的双链DNA,其中正向序列为/rApp/-CGGTTGGAGCTAGAAATAGCAAGTCAACCTAACGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-/NH2C6/(SEQ ID NO:3);反向序列为 /NH2C6/-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCGTTAGGTTGACTTGCTATTTCTAGCTCCAACC-/ddG/(SEQ ID NO:4)。The preparation method of the enzymatic target sequence random sgRNA library according to claim 1, wherein the sgRNA backbone described in step (5) is a double-stranded DNA formed by complementary pairing of two single-stranded DNAs, wherein the forward sequence is/ rApp/-CGGTTGGAGCTAGAAATAGCAAGTCAACCTAACGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-/NH2C6/ (SEQ ID NO: 3); reverse sequence is /NH2C6/-AAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCGTTAGGTTGACTTGCTATTTCTAGCTCC AACC-/ddG/ (SEQ ID NO: 4).
  7. 根据权利要求6所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(5)中使用T4 DNA连接酶连接sgRNA骨架与双链DNA。The preparation method of enzymatic target sequence random sgRNA library according to claim 6, wherein, use T4 DNA ligase to connect sgRNA backbone and double-stranded DNA in step (5).
  8. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(7)采用T4 DNA连接酶,所述T7启动子的正向序列为/NH2C6/-TTCTAATACGACTCACTATAGGNN(SEQ ID NO:5),反向序列为/ddC/-CTATAGTGAGTCGTATTAGAA-/NH2C6/(SEQ ID NO:6)。The preparation method of the enzymatic target sequence random sgRNA library according to claim 1, wherein, step (7) adopts T4 DNA ligase, and the forward sequence of the T7 promoter is /NH2C6/-TTCTAATACGACTCACTATAGGNN (SEQ ID NO: 5), the reverse sequence is /ddC/-CTATAGTGAGTCGTATTAGAA-/NH2C6/(SEQ ID NO:6).
  9. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(8)中所述的扩增反应采用的引物对的正向序列为TTCTAATACGACTCACTATAGG(SEQ ID NO:7),反向序列为AAAAGCACCGACTCGGTGCC(SEQ ID NO:8)。The preparation method of the enzymatic target sequence random sgRNA library according to claim 1, wherein, the forward sequence of the primer pair used in the amplification reaction described in step (8) is TTCTAATACGACTCACTATAGG (SEQ ID NO: 7), reverse The directed sequence is AAAAGCACCGACTCGGTGCC (SEQ ID NO: 8).
  10. 根据权利要求1所述的酶法靶序列随机sgRNA文库的制备方法,其中,步骤(9)采用T7 RNA聚合酶进行转录,采用RNA回收磁珠回收sgRNA文库。The preparation method of enzymatic target sequence random sgRNA library according to claim 1, wherein, step (9) adopts T7 RNA polymerase to transcribe, adopts RNA recovery magnetic beads to reclaim the sgRNA library.
PCT/CN2022/140437 2021-12-21 2022-12-20 Method for preparing random sgrna library of target sequence by means of enzymatic method WO2023116718A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111586539.6 2021-12-21
CN202111586539.6A CN114293264A (en) 2021-12-21 2021-12-21 Preparation method of enzyme method target sequence random sgRNA library

Publications (1)

Publication Number Publication Date
WO2023116718A1 true WO2023116718A1 (en) 2023-06-29

Family

ID=80969718

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/140437 WO2023116718A1 (en) 2021-12-21 2022-12-20 Method for preparing random sgrna library of target sequence by means of enzymatic method

Country Status (2)

Country Link
CN (1) CN114293264A (en)
WO (1) WO2023116718A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114293264A (en) * 2021-12-21 2022-04-08 翌圣生物科技(上海)股份有限公司 Preparation method of enzyme method target sequence random sgRNA library

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146862A (en) * 1997-05-09 2000-11-14 Unitaka Ltd. Thermostable diaphorase gene
CN114293264A (en) * 2021-12-21 2022-04-08 翌圣生物科技(上海)股份有限公司 Preparation method of enzyme method target sequence random sgRNA library

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103668471B (en) * 2013-12-19 2015-09-30 上海交通大学 A kind of method of constructed dna high-throughput sequencing library and matched reagent box thereof
KR20160103953A (en) * 2015-02-25 2016-09-02 연세대학교 산학협력단 Method for target DNA enrichment using CRISPR system
AU2016263026A1 (en) * 2015-05-15 2017-11-09 Pioneer Hi-Bred International, Inc. Guide RNA/Cas endonuclease systems
CA3001683A1 (en) * 2015-06-05 2016-12-08 The Regents Of The University Of California Methods and compositions for generating crispr/cas guide rnas
WO2017100343A1 (en) * 2015-12-07 2017-06-15 Arc Bio, Llc Methods and compositions for the making and using of guide nucleic acids
US10669539B2 (en) * 2016-10-06 2020-06-02 Pioneer Biolabs, Llc Methods and compositions for generating CRISPR guide RNA libraries
US20200255823A1 (en) * 2016-10-06 2020-08-13 Pioneer Biolabs, Llc Guide strand library construction and methods of use thereof
CA3065384A1 (en) * 2017-06-07 2018-12-13 Arc Bio, Llc Creation and use of guide nucleic acids
CN107099850B (en) * 2017-06-19 2018-05-04 东北农业大学 A kind of method that CRISPR/Cas9 genomic knockouts library is built by digestion genome
CN108103586A (en) * 2017-10-13 2018-06-01 上海科技大学 A kind of CRISPR/Cas9 random libraries and its structure and application
CN110158157B (en) * 2018-02-13 2021-02-02 浙江大学 Method for synthesizing DNA library with fixed length and specific terminal sequence based on template material
CN112313241A (en) * 2018-04-17 2021-02-02 总医院公司 Sensitive in vitro assay of substrate preference and site for nucleic acid binding, modification, and cleavage reagents
WO2020172199A1 (en) * 2019-02-19 2020-08-27 Pioneer Biolabs, Llc Guide strand library construction and methods of use thereof
CN110791814A (en) * 2019-10-07 2020-02-14 深圳易倍科华生物科技有限公司 Rapid single-chain library building method
CN111455469B (en) * 2020-04-07 2023-08-18 深圳易倍科华生物科技有限公司 Single-chain rapid library construction method and library construction instrument
CN113322523B (en) * 2021-06-17 2024-03-19 翌圣生物科技(上海)股份有限公司 RNA rapid library construction method and application thereof
CN113584134B (en) * 2021-09-06 2024-01-30 青岛金斯达生物技术有限公司 Isothermal nucleic acid detection system based on CRISPR-Cas9, and method and application thereof
CN113699214A (en) * 2021-10-27 2021-11-26 翌圣生物科技(上海)股份有限公司 Sequencing method based on gene capture technology
CN114277447A (en) * 2021-12-21 2022-04-05 翌圣生物科技(上海)股份有限公司 Preparation method of target sequence random sgRNA full-coverage group

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146862A (en) * 1997-05-09 2000-11-14 Unitaka Ltd. Thermostable diaphorase gene
CN114293264A (en) * 2021-12-21 2022-04-08 翌圣生物科技(上海)股份有限公司 Preparation method of enzyme method target sequence random sgRNA library

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YATES JOSHUA D, RUSSELL ROBERT C, BARTON NATHANIEL J, YOST H JOSEPH, HILL JONATHON T: "A simple and rapid method for enzymatic synthesis of CRISPR-Cas9 sgRNA libraries", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 49, no. 22, 16 December 2021 (2021-12-16), GB , pages e131 - e131, XP055924395, ISSN: 0305-1048, DOI: 10.1093/nar/gkab838 *

Also Published As

Publication number Publication date
CN114293264A (en) 2022-04-08

Similar Documents

Publication Publication Date Title
AU2021212165B2 (en) Genomewide unbiased identification of dsbs evaluated by sequencing (guide-seq)
US10669571B2 (en) Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using CRISPR/Cas system proteins
WO2023116681A1 (en) Method for preparing random sgrna full-coverage group of target sequence
WO2019041296A1 (en) Base editing system and method
EP3555305B1 (en) Method for increasing throughput of single molecule sequencing by concatenating short dna fragments
WO2016058134A1 (en) Linker element and method of using same to construct sequencing library
WO2016082130A1 (en) Method and reagent for constructing nucleic acid double-linker single-strand cyclical library
CN110607353B (en) Method and kit for rapidly preparing DNA sequencing library by utilizing efficient ligation technology
WO2023116718A1 (en) Method for preparing random sgrna library of target sequence by means of enzymatic method
JP2023519782A (en) Methods of targeted sequencing
JP7436493B2 (en) Normalization control for handling low sample input in next-generation sequencing
WO2017215517A1 (en) Method for removing 5' and 3' linker connection by-products in sequencing library construction
WO2019090621A1 (en) Hooked probe, method for ligating nucleic acid and method for constructing sequencing library
WO2018086512A1 (en) Plant genome site-specific knock-in method
CN108265047B (en) Method and kit for non-specific replication of DNA fragments
CN113025689A (en) Library construction method for modified small RNA and application thereof
WO2016058121A1 (en) Nucleic acid fragmentation method and sequence combination
CN112176422A (en) Construction method of RNA library
CN117343989B (en) Targeting library construction method for detecting gene fusion
WO2018126584A1 (en) Circular transposon complex and application thereof
CN111748611A (en) PCR primer and application thereof in DNA fragment connection
CN113005178B (en) Construction method of RNA library and kit
CN117343929B (en) PCR random primer and method for enhancing targeted enrichment by using same
US11085042B2 (en) Method of producing DNA and DNA library
US20240182951A1 (en) Methods for targeted nucleic acid sequencing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22910030

Country of ref document: EP

Kind code of ref document: A1